Does CYTARABINE Cause Primary hypogonadism? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Primary hypogonadism have been filed in association with CYTARABINE (cytarabine). This represents 0.0% of all adverse event reports for CYTARABINE.
14
Reports of Primary hypogonadism with CYTARABINE
0.0%
of all CYTARABINE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Primary hypogonadism From CYTARABINE?
Of the 14 reports, 6 (42.9%) required hospitalization.
Is Primary hypogonadism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Primary hypogonadism?
CYCLOPHOSPHAMIDE (28)
BUSULFAN (14)
ETOPOSIDE (14)
BUSULFEX (12)
FINASTERIDE (12)
FLUDARABINE (10)
VINCRISTINE (9)
DOXORUBICIN (8)
IDARUBICIN (8)
METHOTREXATE (8)
Which CYTARABINE Alternatives Have Lower Primary hypogonadism Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB